The editorial team of Journal of Immunological Disorders and Immunotherapy (ISSN: 2593-8509) are overwhelmed by the response and eagerness of the academic and research contributors to publish with the journal and take part in the year-long celebrations. During this year we look forward to taking some initiates that would encourage and reward our prospective customers. It gives us great pleasure in announcing the call for paper on the special and hefty discount of up to 20 percent on one-time article processing charge.

Prospective academics and scientists are encouraged to utilize this opportunity to get their contents reviewed, processed and published at relatively faster pace and at low expenditure. In addition to this the authors who publish with us during the year-long celebrations will also be eligible for academic awards recommended by the editorial panel.

The scope and discipline of Immunological Disorders and Immunotherapy (ISSN: 2593-8509) is very broad which includes immune disorders caused by genetic variation related to monogenic as well as polygenic disorders, due to immune system over expressive or deformities, wide range of congenital or acquired disorders. Rapid advances in medicinal research, there is more need of advanced and durable study in Immunological Disorders and Immunotherapy field. The Journal of Immunological Disorders and Immunotherapy provides the platform to publish these new ideas.

Celebrating the decade of successful publication history, the journal reiterates its commitment to promote systematic enquiry and explorations into the health and metabolic risk posed by increasing prevalence of Internal Medicine across the world. The journal invites different types of science communications including original research article, systematic reviews, short note communications, case reports, Editorials, letters to the Editors and expert opinions & commentaries from different regions for publication.

A standard editorial tracking system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing. Manuscripts can be uploaded at www.longdom.org/submissions/immunological-disorders-immunotherapy.html or forwarded to the editorial office at immunedisord@immunologyjournals.com

• After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days. A 21-day window time frame is allotted for peer-review process wherein multiple experts are contacted. Author proof is generated within 7 working days after the acceptance decision.
• The HTML and PDF formats of the accepted articles are hosted on the website after assigning DOI number by the Cross Ref. The journal publishes the articles under open access policy with creative commons attribution license permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.
• In addition to archiving, the published articles are also promoted through various scientific and social media as well as through International indexation and abstracting services.

Best regards,

John Morris

Journal Coordinator

Immunological Disorders & Immunotherapy

Whatsapp: +44-1904-929220